Mark van Oene
Chief Operating Officer en PACIFIC BIOSCIENCES OF CALIFORNIA, INC. .
Fortuna: 6 M $ al 31/03/2024
Perfil
Mark David Van Oene ocupa el cargo de director de operaciones en Pacific Biosciences of California, Inc. También forma parte del consejo de BlueGnome Ltd. y de Illumina Cambridge Ltd. Anteriormente fue director comercial y vicepresidente senior de Illumina, Inc. y director de servicios de genotipado en Ellipsis Biotherapeutics Corp. Se licenció en la Universidad de Western Ontario y se doctoró en la Universidad de Toronto.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/03/2024 | 1 668 826 ( 0.61% ) | 6 M $ | 31/03/2024 |
Cargos activos de Mark van Oene
| Empresas | Cargo | Inicio |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Chief Operating Officer | 08/01/2021 |
Illumina Cambridge Ltd.
 Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Director/Board Member | - |
BlueGnome Ltd.
 BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Director/Board Member | 22/01/2018 |
Dante Labs, Inc.
 Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Director/Board Member | 24/08/2021 |
Antiguos cargos conocidos de Mark van Oene.
| Empresas | Cargo | Fin |
|---|---|---|
Ellipsis Biotherapeutics Corp.
 Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Corporate Officer/Principal | - |
| ILLUMINA, INC. | Corporate Officer/Principal | - |
Formación de Mark van Oene.
| University of Toronto | Doctorate Degree |
| University of Western Ontario | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
BlueGnome Ltd.
BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Technology Services |
Ellipsis Biotherapeutics Corp.
Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Commercial Services |
Dante Labs, Inc.
Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Health Services |
Illumina Cambridge Ltd.
Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Commercial Services |
- Bolsa de valores
- Insiders
- Mark van Oene
